Detalhe da pesquisa
1.
Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.
Clin Nephrol
; 77(3): 246-53, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22377258
2.
Steroid avoidance in renal transplant patients maintained on a cyclosporine-based protocol.
Exp Clin Transplant
; 5(2): 664-9, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18194118
3.
Outcomes of Early Steroid Withdrawal in Recipients of Deceased-Donor Expanded Criteria Kidney Transplants in the Era of Induction Therapy.
Exp Clin Transplant
; 14(3): 287-93, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27221720
4.
Impact of steroid maintenance on the outcomes in first-time deceased donor kidney transplant recipients: Analysis by induction type.
World J Transplant
; 4(3): 188-95, 2014 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25346892
5.
Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression.
Transplantation
; 93(8): 799-805, 2012 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22290269
6.
Treatment of antibody-mediated rejection in kidney transplant recipients: a single-center experience with a bortezomib-based regimen.
Exp Clin Transplant
; 10(6): 609-13, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23216567
7.
Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial.
Clin J Am Soc Nephrol
; 7(9): 1498-506, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22745272
8.
Transplantation and the primary care physician.
Adv Chronic Kidney Dis
; 18(6): 433-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22098662